- Home
- QCLS vs BGLC Comparison
QCLS vs BGLC Comparison
Compare QCLS & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QCLS
- BGLC
- Stock Information
- Founded
- QCLS 2014
- BGLC 2017
- Country
- QCLS United States
- BGLC Malaysia
- Employees
- QCLS N/A
- BGLC N/A
- Industry
- QCLS Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BGLC Medical Specialities
- Sector
- QCLS Health Care
- BGLC Health Care
- Exchange
- QCLS Nasdaq
- BGLC Nasdaq
- Market Cap
- QCLS 12.5M
- BGLC 10.4M
- IPO Year
- QCLS N/A
- BGLC N/A
- Fundamental
- Price
- QCLS $3.80
- BGLC $5.12
- Analyst Decision
- QCLS
- BGLC
- Analyst Count
- QCLS 0
- BGLC 0
- Target Price
- QCLS N/A
- BGLC N/A
- AVG Volume (30 Days)
- QCLS 1.3M
- BGLC 98.6K
- Earning Date
- QCLS 11-13-2025
- BGLC 11-14-2025
- Dividend Yield
- QCLS N/A
- BGLC N/A
- EPS Growth
- QCLS N/A
- BGLC N/A
- EPS
- QCLS N/A
- BGLC N/A
- Revenue
- QCLS N/A
- BGLC $9,551,559.00
- Revenue This Year
- QCLS N/A
- BGLC N/A
- Revenue Next Year
- QCLS N/A
- BGLC N/A
- P/E Ratio
- QCLS N/A
- BGLC N/A
- Revenue Growth
- QCLS N/A
- BGLC 4.01
- 52 Week Low
- QCLS $3.24
- BGLC $2.01
- 52 Week High
- QCLS $174.27
- BGLC $15.60
- Technical
- Relative Strength Index (RSI)
- QCLS N/A
- BGLC 46.78
- Support Level
- QCLS N/A
- BGLC $5.02
- Resistance Level
- QCLS N/A
- BGLC $5.40
- Average True Range (ATR)
- QCLS 0.00
- BGLC 0.34
- MACD
- QCLS 0.00
- BGLC -0.02
- Stochastic Oscillator
- QCLS 0.00
- BGLC 36.95
About QCLS Q/C Technologies Inc. Common Stock
Q/C Technologies Inc is engaged in building blockchain infrastructure that is faster and more energy-efficient. The company uses laser-based processors inspired by quantum technology that can solve complex problems at the speed of light. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.